Please login to the form below
Digital intelligence blog
Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools
J&J's Care4Today brand joins Twitter
Firm's Janssen Healthcare Innovation unit also makes its debut on the social network
Johnson & Johnson has expanded its use of Twitter, bringing its Care4Today brand and Janssen Healthcare Innovation unit to the social network.
Care4Today currently encompasses four areas - Mobile Health Manager, Mental Health Solutions, Heart Health Solutions and Orthopaedic Solutions - and forms part of transform J&J's plans to transform itself from a product-centric pharma business to a broader healthcare company.
The company, which came out top in our recent Digital Futures survey, has also brought its innovation unit to Twitter. Janssen Healthcare Innovation is set up as an entrepreneurial team within Janssen's R&D arm and behind a range of initiatives, including Care4Today.
Subscribe to our email news alerts
- Roche to acquire Carmot Therapeutics in deal worth up to $3.1bn
- Eli Lilly’s Jaypirca granted FDA accelerated approval for non-Hodgkin lymphomas
- UK-India research project trialling easy-to-use UTI test to support fight against AMR
- Cancer Research UK and Guardant collaborate to advance cancer detection and treatment
- Give the gift of positive change
- Apple Vision Pro: challenges and opportunities for pharma
No results were found
PMHub
IPG Health Medical Communications
We are the world's most celebrated and awarded Medical Communications agencies. We are 800 experts obsessed with combining science, creativity...
Latest intelligence
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
